USPTO serial 79218926
G GNA BIOSOLUTIONS
Reviewed by CopyMark Law Group
Reg. 5705753Status 709
- Filing date
- Status date
- Registration date
- Mar 26, 2019
- Examiner
- THOMAS, JULIE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with G GNA BIOSOLUTIONS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jacqueline Zion
Jacqueline Zion Pearl Cohen Zedek Latzer Baratz LLP1500 Broadway, 12th FLNew York, NY 10036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic chemical reagents for medical use; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use; diagnostic preparations for veterinary purposes; diagnostic biomarker reagents for medical purposes; diagnostic testing materials for medical use testing of the intended performance characteristics of bioanalytical methods; diagnostic reagents for medical use; clinical medical reagents; reagents for in-vitro laboratory use for medical purposes; reagents for in-vitro laboratory use for veterinary purposes; reagents for microbiological analysis for medical purposes; reagents for microbiological analysis for veterinary purposes; reagents for use in diagnostic tests for medical purposes; reagents for use with analyzers for veterinary purposes; reagents for use with analyzers for medical purposes | SECTION 71 - CANCELLED | — |
| 009 | Biochips for research or scientific purposes; diagnostic apparatus, not for medical purposes, namely, for bioanalytical purposes, in particular for nucleic acid amplification and detection; computer software applications, downloadable, for setting up, conducting, interpreting, and storing bioanalytical measurements, in particular for nucleic acid amplification and detection; lasers, not for medical purposes; chemistry apparatus and instruments, namely, for bioanalytical procedures; recorded computer programs for setting up, conducting interpreting, and storing bioanalytical measurements, in particular for nucleic acid amplification and detection; downloadable computer software programs for setting up, conducting, interpreting, and storing bioanalytical measurements, in particular for nucleic acid amplification and detection; recorded computer software for setting up, conducting, interpreting, and storing bioanalytical measurements, in particular for nucleic acid amplification and detection; DNA chips; air analysis apparatus; optical apparatus and instruments, namely, for bioanalytical measurements; laboratory equipment, namely, test tubes; probes for scientific purposes for conducting bioanalytical measurements, in particular for nucleic acid amplification and detection; scientific, electrotechnical, electronic, optical, measuring, signaling, checking, and supervision apparatus and instruments, namely, for conducting bioanalytical procedures, in particular sample preparation, nucleic acid amplification and detection; laboratory apparatus, analysis apparatus and parts therefor, namely, for conducting bioanalytical procedures, in particular sample preparation, nucleic acid amplification and detection; scanners; laboratory equipment, in particular apparatus for bioanalysis, in particular temperature cyclers, fluorescence scanners and apparatuses for nucleic acid amplification and detection, in particular using a cartridge for preparing samples, purifying nucleic acids and amplifying nucleic acids and for detecting nucleic acids; disposable articles for laboratory apparatus, in particular sample and receptacles, mainly consisting of plastic; parts and fittings for all the aforesaid, namely, mechanical, electrical, and structural modules or components | SECTION 71 - CANCELLED | — |
| 010 | Apparatus for DNA and RNA exams for medical purposes; blood testing apparatus; diagnostic apparatus for medical purposes for detecting target molecules of interest in a sample, in particular a patient sample; lasers for medical purposes; medical apparatus, in particular apparatus for bioanalysis, namely, the extraction, amplification, and detection of target molecules of interest; diagnostic apparatus for veterinary purposes for detecting target molecules of interest; automatic analyzers for medical diagnosis for detecting target molecules of interest; medical apparatus and instruments, namely, for detecting target molecules of interest; medical instruments for infectious disease testing, namely, human or veterinary pathogens; medical and veterinary apparatus and instruments, namely, for processing samples, and detecting target molecules of interest; tools for veterinary diagnostics, namely, detecting target molecules of interest | SECTION 71 - CANCELLED | — |
| 042 | Updating of computer software; maintenance of software; biological research; cloud computing featuring software for setting up, conducting, interpreting, and storing bioanalytical measurements, in particular for nucleic acid amplification and detection; chemical laboratories; chemical analysis; bacteriological research; chemical research; research and development of new products for others; conducting clinical trials for others for scientific and medical research; medical and scientific research services; scientific laboratory services; clinical laboratory services for scientific purposes; scientific and technological services and research and design relating thereto, namely, conducting bioanalytical procedures; industrial analysis and research services, namely, conducting bioanalytical procedures, in particular nucleic acid amplification and detection for scientific research purposes; design and development of computer hardware and software; scientific analysis of cells, proteins, nucleic acids and other molecules between 50 and 10 000 daltons, for DNA sequencing and genotyping, for detecting DNS mutations, for gene expression profiling, in particular relating to the conducting of high throughput screening methods; information and advice relating to the aforesaid services; development and conducting of scientific analyses and diagnostic methods, for others | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by GNA Biosolutions GmbH
- Other trademarks owned by GNA Biosolutions GmbH
- Other trademarks owned by GNA Biosolutions GmbH
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named G GNA BIOSOLUTIONS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 10, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Oct 10, 2025 | C71T | CANCELLED SECTION 71 | — |
| Mar 26, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 9, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 16, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 25, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 25, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 26, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 5, 2019 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 26, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 20, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 20, 2019 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 8, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 8, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 19, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 30, 2018 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 29, 2018 | ALIE | ASSIGNED TO LIE | — |
| Nov 8, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 8, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 8, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 8, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 8, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 6, 2018 | RFNP | REFUSAL PROCESSED BY IB | — |
| Aug 7, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 9, 2018 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jun 26, 2018 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jun 9, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 24, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 23, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 23, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 23, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 17, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 28, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 28, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 15, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 14, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 31, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 28, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 25, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 19, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |